|
1.
|
Gorlick R and Khanna C: Osteosarcoma. J
Bone Miner Res. 25:683–691. 2010. View
Article : Google Scholar
|
|
2.
|
Gougelet A, Pissaloux D, Besse A, et al:
Micro-RNA profiles in osteosarcoma as predictive tool for
ifosfamide response. Int J Cancer. 129:680–690. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
John B, Enright AJ, Aravin A, et al: Human
MicroRNA targets. PloS Biol. 2:e3632004. View Article : Google Scholar
|
|
4.
|
Lagos-Quintana M, Rauhut R, Yalcin A, et
al: Identification of tissue-specific microRNAs from mouse. Curr
Biol. 12:735–39. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Lee RC and Ambros V: An extensive class of
small RNAs in Caenorhabditis elegans. Science. 294:862–64.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Sempere LF, Freemantle S, Pitha-Rowe I, et
al: Expression profiling of mammalian microRNAs uncovers a subset
of brain-expressed microRNAs with possible roles in murine and
human neuronal differentiation. Genome Biol. 5:R132004. View Article : Google Scholar
|
|
7.
|
Lim LP, Lau NC, Weinstein EG, et al: The
microRNAs of Caenorhabditis elegans. Genes Dev. 17:991–1008.
2003.
|
|
8.
|
Esquela-Kerscher A and Slack FJ: Oncomirs
- microRNAs with a role in cancer. Nat Rev Cancer. 6:259–269. 2006.
View Article : Google Scholar
|
|
9.
|
Calin GA, Sevignani C, Dumitru CD, et al:
Human microRNA genes are frequently located at fragile sites and
genomic regions involved in cancers. Proc Natl Acad Sci USA.
101:2999–3004. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Wu W, Sun M, Zou GM and Chen J: MicroRNA
and cancer: current status and prospective. Int J Cancer.
120:953–960. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Montanini L, Lasagna L, Barili V, et al:
MicroRNA cloning and sequencing in osteosarcoma cell lines:
differential role of miR-93. Cell Oncol (Dordr). 35:29–41. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
He C, Xiong J, Hu X, et al: Functional
elucidation of MiR-34 in osteosarcoma cells and primary tumor
samples. Biochem Biophys Res Commun. 388:35–40. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Kauppinen S, Vester B and Wengel J: Locked
nucleic acid: high-affinity targeting of camplementary RNA for
RNomics. Handb Exp Pharmacol. 173:405–422. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Yang YH, Dudoit S, Luu P, et al:
Normalization for cDNA microarray data :a robust composite method
addressing single and multiple slide systematic variation. Nucleic
Acids Res. 30:e152002. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Yan D, Dong Xda E, Chen X, et al:
MicroRNA-1/206 targets c-Met and inhibits rhabdomyosarcoma
development. J Biol Chem. 284:29596–29604. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Hu G, Chen D, Li X, et al: miR-133b
regulates the MET proto-oncogene and inhibits the growth of
colorectal cancer cells in vitro and in vivo. Cancer Biol Ther.
10:190–197. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Hattinger CM, Pasello M, Ferrari S, et al:
Emergine drugs for high-grade osteosarcoma. Export Opin Emerg
Drugs. 15:615–634. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Zhang H, Cai X, Wang Y, et al:
microRNA-143, down-regulated in osteosarcoma, promotes apoptosis
and suppresses tumorigenicity by targeting Bcl-2. Oncol Rep.
24:1363–1369. 2010.PubMed/NCBI
|
|
19.
|
Ziyan W, Shuhua Y, Xiufang W and Xiaoyun
L: MicroRNA-21 is involved in osteosarcoma cell invasion and
migration. Med Oncol. 28:1469–1474. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Song B, Wang Y, Titmus MA, et al:
Molecular mechanism of chemoresistance by miR-215 in osteosarcoma
and colon cancer cells. Mol Cancer. 9:962010. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Bar N and Dikstein R: MiR-22 forms a
regulatory loop in PTEN/AKT pathway and modulates signaling
kinetics. PloS One. 27:e108592010. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Huang Z, Huang S, Wang Q, et al:
MicroRNA-95 promotes cell proliferation and targets sorting Nexin 1
in human colorectal carcinoma. Cancer Res. 71:2582–589. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Kumarswamy R, Mudduluru G, Ceppi P, et al:
MicroRNA-30a inhibits epithelial-to-mesenchymal transition by
targeting Snail and is downregulated in non small cell lung cancer.
Int J Cancer. 130:2044–2053. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Lee DY, Deng Z, Wang CH and Yang BB:
MicroRNA-378 promotes cell survival, tumor growth, and angiogenesis
by targeting SuFu and Fus-1 expression. Proc Natl Acad Sci USA.
104:20350–20355. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Chen JF, Mandel EM, Thomson JM, et al: The
role of microRNA-1 and microRNA-133 in skeletal muscle
proliferation and differentiation. Nat Genet. 38:228–233. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Carleton M, Cleary MA and Linsley PS:
MicroRNAs and cell cycle regulation. Cell Cycle. 6:2127–2132. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Crawford M, Batte K, Yu L, et al: MicroRNA
133B targets pro-survival molecules MCL-1 and BCL2L2 in lung
cancer. Biochem Biophys Res Commun. 388:483–489. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Taulli R, Bersani F, Foglizzo V, et al:
The muscle-specific microRNA miR-206 blocks human rhabdomyosarcoma
growth in xenotransplanted mice by promoting myogenic
differentiation. J Clin Invest. 119:2366–2378. 2009.PubMed/NCBI
|
